| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cognitive neuroscience approach to individual differences in sensitivity to reward
|
Ávila, C.
|
|
2008
|
|
2-3 |
p. 191-203
|
artikel
|
| 2 |
Action of botulinum neurotoxins in the central nervous system: Antiepileptic effects
|
Bozzi, Yuri
|
|
2006
|
|
2-3 |
p. 197-203
|
artikel
|
| 3 |
Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry
|
Kalivas, Peter W.
|
|
2008
|
|
2-3 |
p. 185-189
|
artikel
|
| 4 |
Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise
|
Palomo, Tomas
|
|
2008
|
|
2-3 |
p. 151-168
|
artikel
|
| 5 |
Botulinum neurotoxin — from laboratory to bedside
|
Foster, Keith A.
|
|
2006
|
|
2-3 |
p. 133-140
|
artikel
|
| 6 |
Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting
|
Singh, Bal Ram
|
|
2006
|
|
2-3 |
p. 73-92
|
artikel
|
| 7 |
Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms
|
Vittal, Harsha
|
|
2006
|
|
2-3 |
p. 149-159
|
artikel
|
| 8 |
Botulinum toxin therapy for cervical dystonia
|
Jankovic, Joseph
|
|
2006
|
|
2-3 |
p. 145-148
|
artikel
|
| 9 |
Botulinum toxin treatment of children with cerebral palsy — a short review of different injection techniques
|
Schroeder, A. S.
|
|
2006
|
|
2-3 |
p. 189-196
|
artikel
|
| 10 |
Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia
|
Lewis, David A.
|
|
2008
|
|
2-3 |
p. 237-248
|
artikel
|
| 11 |
Characterization ofClostridial botulinum neurotoxin channels in neuroblastoma cells
|
Fischer, Audrey
|
|
2006
|
|
2-3 |
p. 93-100
|
artikel
|
| 12 |
Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia
|
Blackwood, D. H. R.
|
|
2008
|
|
2-3 |
p. 113-120
|
artikel
|
| 13 |
Clinical perspectives on the genetics of schizophrenia: A bottom-up orientation
|
Verhoeven, Willem M. A.
|
|
2008
|
|
2-3 |
p. 141-150
|
artikel
|
| 14 |
Clinical use of non-a botulinum toxins: botulinum toxin type B
|
Dressler, Dirk
|
|
2006
|
|
2-3 |
p. 121-125
|
artikel
|
| 15 |
Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F
|
Eleopra, Roberto
|
|
2006
|
|
2-3 |
p. 127-131
|
artikel
|
| 16 |
Cognitive functioning and negative symptoms in first episode schizophrenia: Different patterns of correlates
|
RodrÍguez-SÁnchez, JosÉ Manuel
|
|
2008
|
|
2-3 |
p. 227-235
|
artikel
|
| 17 |
Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control
|
Archer, Trevor
|
|
2008
|
|
2-3 |
p. 205-225
|
artikel
|
| 18 |
Comparing the prefrontal cortex of rats and primates: Insights from electrophysiology
|
Seamans, Jeremy K
|
|
2008
|
|
2-3 |
p. 249-262
|
artikel
|
| 19 |
Death and neuroprotection of retinal ganglion cells after different types of injury
|
Vidal-Sanz, Manuel
|
|
2000
|
|
2-3 |
p. 215-227
|
artikel
|
| 20 |
Death and neuroprotection of retinal ganglion cells after different types of injury
|
Vidal-Sanz, Manuel
|
|
|
|
2-3 |
p. 215-227
|
artikel
|
| 21 |
Dopamine and reward: The anhedonia hypothesis 30 years on
|
Wise, Roy A.
|
|
2008
|
|
2-3 |
p. 169-183
|
artikel
|
| 22 |
Dopamine receptor supersensitivity: Development, mechanisms, presentation, and clinical applicability
|
Kostrzewa, Richard M.
|
|
2008
|
|
2-3 |
p. 121-128
|
artikel
|
| 23 |
Excitotoxicity of quinolinic acid: Modulation by endogenous antagonists
|
Jhamandas, K. H.
|
|
2000
|
|
2-3 |
p. 139-155
|
artikel
|
| 24 |
Excitotoxicity of quinolinic acid: Modulation by endogenous antagonists
|
Jhamandas, K. H.
|
|
|
|
2-3 |
p. 139-155
|
artikel
|
| 25 |
Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia
|
Lodge, Daniel J.
|
|
2008
|
|
2-3 |
p. 97-104
|
artikel
|
| 26 |
Long term effects of intra-articular botulinum toxin a for refractory joint pain
|
Mahowald, Maren L.
|
|
2006
|
|
2-3 |
p. 179-188
|
artikel
|
| 27 |
Management of bladder, prostatic and pelvic floor disorders
|
Brisinda, Giuseppe
|
|
2006
|
|
2-3 |
p. 161-172
|
artikel
|
| 28 |
Muscle fiber orientation in muscles commonly injected with botulinum toxin: An anatomical pilot study
|
Deshpande, Supreet
|
|
2006
|
|
2-3 |
p. 115-120
|
artikel
|
| 29 |
Neurophysiological effects of botulinum toxin type a
|
Abbruzzese, G.
|
|
2006
|
|
2-3 |
p. 109-114
|
artikel
|
| 30 |
Neuroprotection in alzheimer’s disease — new strategies for treatment
|
Nordberg, Agneta
|
|
2000
|
|
2-3 |
p. 157-165
|
artikel
|
| 31 |
Neuroprotection in alzheimer’s disease — new strategies for treatment
|
Nordberg, Agneta
|
|
|
|
2-3 |
p. 157-165
|
artikel
|
| 32 |
Neuroprotective and neurorestorative strategies for neuronal injury
|
Beal, M. Flint
|
|
2000
|
|
2-3 |
p. 71-84
|
artikel
|
| 33 |
Neuroprotective and neurorestorative strategies for neuronal injury
|
Beal, M. Flint
|
|
|
|
2-3 |
p. 71-84
|
artikel
|
| 34 |
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
|
Danysz, Wojciech
|
|
2000
|
|
2-3 |
p. 85-97
|
artikel
|
| 35 |
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
|
Danysz, Wojciech
|
|
|
|
2-3 |
p. 85-97
|
artikel
|
| 36 |
Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals
|
Chiueh, Chuang Chin
|
|
2000
|
|
2-3 |
p. 293-310
|
artikel
|
| 37 |
Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals
|
Chiueh, Chuang Chin
|
|
|
|
2-3 |
p. 293-310
|
artikel
|
| 38 |
Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease
|
Yebenes, Justo Garcia de
|
|
2000
|
|
2-3 |
p. 115-137
|
artikel
|
| 39 |
Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease
|
de Yebenes, Justo Garcia
|
|
|
|
2-3 |
p. 115-137
|
artikel
|
| 40 |
NMDA antagonist and antipsychotic actions in cortico-subcortical circuits
|
Kargieman, Lucila
|
|
2008
|
|
2-3 |
p. 129-140
|
artikel
|
| 41 |
No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm
|
Lorenzano, C.
|
|
2006
|
|
2-3 |
p. 141-144
|
artikel
|
| 42 |
Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia, alzheimer’s type
|
Lobo, Antonio
|
|
2008
|
|
2-3 |
p. 263-272
|
artikel
|
| 43 |
Oxidative neuropathology and putative chemical entities for alzheimer’s disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants
|
Rupniak, H. Thomas R.
|
|
2000
|
|
2-3 |
p. 167-178
|
artikel
|
| 44 |
Oxidative neuropathology and putative chemical entities for alzheimer’s disease: Neuroprotective effects of salen-manganese catalytic anti-oxidants
|
Rupniak, H. Thomas R.
|
|
|
|
2-3 |
p. 167-178
|
artikel
|
| 45 |
Poster abstracts
|
|
|
2006
|
|
2-3 |
p. 225-246
|
artikel
|
| 46 |
Prospects for redox-based therapy in neurodegenerative diseases
|
Friedlich, Avi L.
|
|
2000
|
|
2-3 |
p. 229-237
|
artikel
|
| 47 |
Prospects for redox-based therapy in neurodegenerative diseases
|
Friedlich, Avi L.
|
|
|
|
2-3 |
p. 229-237
|
artikel
|
| 48 |
Re-engineering the target specificity of clostridial neurotoxins - a route to novel therapeutics
|
Foster, Keith A.
|
|
2006
|
|
2-3 |
p. 101-107
|
artikel
|
| 49 |
Restoration and putative protection in parkinsonism
|
Archer, Trevor
|
|
2000
|
|
2-3 |
p. 251-292
|
artikel
|
| 50 |
Restoration and putative protection in parkinsonism
|
Archer, Trevor
|
|
|
|
2-3 |
p. 251-292
|
artikel
|
| 51 |
Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease
|
Kostrzewa, Richard M.
|
|
2000
|
|
2-3 |
p. 239-250
|
artikel
|
| 52 |
Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease
|
Kostrzewa, Richard M.
|
|
|
|
2-3 |
p. 239-250
|
artikel
|
| 53 |
Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths
|
Palomo, Tomas
|
|
2008
|
|
2-3 |
p. 79-96
|
artikel
|
| 54 |
Speaker abstracts
|
|
|
2006
|
|
2-3 |
p. 217-224
|
artikel
|
| 55 |
Strategies for the protection of dopaminergic neurons against neurotoxicity
|
Gerlach, Manfred
|
|
2000
|
|
2-3 |
p. 99-114
|
artikel
|
| 56 |
Strategies for the protection of dopaminergic neurons against neurotoxicity
|
Gerlach, Manfred
|
|
|
|
2-3 |
p. 99-114
|
artikel
|
| 57 |
The molecular cascades of long-term potentiation underlie memory consolidation of one-trial avoidance in the CA1 region of the dorsal hippocampus, but not in the basolateral amygdala or the neocortex
|
Izquierdo, IvÁn
|
|
2008
|
|
2-3 |
p. 273-294
|
artikel
|
| 58 |
The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs
|
Pedersen, Vera
|
|
2000
|
|
2-3 |
p. 179-203
|
artikel
|
| 59 |
The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs
|
Pedersen, Vera
|
|
|
|
2-3 |
p. 179-203
|
artikel
|
| 60 |
The putative neuroprotective role of dopamine agonists in parkinson’s disease
|
Grandas, Francisco
|
|
2000
|
|
2-3 |
p. 205-213
|
artikel
|
| 61 |
The putative neuroprotective role of dopamine agonists in parkinson’s disease
|
Grandas, Francisco
|
|
|
|
2-3 |
p. 205-213
|
artikel
|
| 62 |
The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop Review: Assays and Detection
|
Shone, Clifford
|
|
2006
|
|
2-3 |
p. 205-216
|
artikel
|
| 63 |
The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome
|
Glaser, Dee Anna
|
|
2006
|
|
2-3 |
p. 173-178
|
artikel
|
| 64 |
Trojan horse or proton force: Finding the right partner(s) for toxin translocation
|
Trujillo, Carolina
|
|
2006
|
|
2-3 |
p. 63-71
|
artikel
|
| 65 |
What is the mechanism whereby cannabis use increases risk of psychosis?
|
Luzi, Sonija
|
|
2008
|
|
2-3 |
p. 105-112
|
artikel
|
Tijdschrift beschrijving